Skip to main content

Table 2 The association between SLC2A3 protein levels and the clinicopathological parameters in 40 GC patients included in the DFS analysis

From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer

Clinicopathological parameters SLC2A3 expression p-value
Low High
Age
 < 60 8 10 p = 0.422
 ≥ 60 8 14  
Gender
 Male 12 18 p = 0.649
 Female 4 6  
pStage
 I 5 2 p = 0.076
 II–IV 11 22  
pT grade
 T1, 2 7 4 p = 0.065
 T3, 4 9 20  
pN grade
 N0 9 10 p = 0.281
 N1–3 7 14  
Total 16 24  
  1. SLC2A3 protein expression was showed no association with age, gender, pathological stage, and TNM grades
  2. GC Gastric cancer, OS overall survival, TNM tumor, N lymph node, M metastasis